ERNA vs HCA · P/E 0.0, rev $582.0K vs P/E 17, rev $75.60B
Eterna Therapeutics Inc (ERNA) versus HCA Holdings Inc (HCA) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Not investment advice. Open the ERNA and HCA stock pages for the full models.
Not investment advice.